Search

STAAR Surgical Co

Chiusa

SettoreSettore sanitario

25.94 3.59

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

24

Massimo

25.48

Metriche Chiave

By Trading Economics

Entrata

5.2M

5.2M

Vendite

36M

94M

EPS

-0.23

Margine di Profitto

5.567

Dipendenti

921

EBITDA

19M

10M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+16.92% upside

Dividendi

By Acuity

Utili prossimi

3 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-135M

1.3B

Apertura precedente

22.35

Chiusura precedente

25.94

Notizie sul Sentiment di mercato

By Acuity

47%

53%

165 / 340 Classifica in Healthcare

STAAR Surgical Co Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

13 ago 2026, 20:02 UTC

Social Media
News

STAAR Surgical shares are lower after UBS cut its price target to $19.00, despite reporting strong second-quarter sales of $93.5 million.

12 ago 2026, 23:56 UTC

Social Media
News

STAAR Surgical shares are lower in after-market hours following an EPS miss, despite reporting second-quarter net sales of $93.5 million, a 111% increase.

11 ago 2026, 20:01 UTC

News

STAAR Surgical Co shares are lower today, reflecting broader market declines amid rising oil prices and inflation concerns ahead of U.S. inflation reports.

10 ago 2026, 20:02 UTC

Social Media
News

Broadwood has acquired over 1 million additional shares of STAAR Surgical, reflecting its long-term strategy, as the stock trades higher since Friday's close.

7 ago 2026, 22:56 UTC

Shares of STAAR Surgical Co. are trading higher in after-market hours, continuing a positive trend amid a supportive market backdrop following a decline in the unemployment rate.

6 ago 2026, 20:03 UTC

STAAR Surgical Co. shares are higher today, reflecting gains since Wednesday's close, though the stock remains below its 20-day moving average.

5 ago 2026, 20:02 UTC

STAAR Surgical shares are lower today, continuing a decline since Tuesday's close amid broader market volatility and external factors not directly impacting the company.

4 ago 2026, 19:51 UTC

STAAR Surgical Co shares are lower as Health Care Supplies sub-sector performance weighs on the stock. No specific news was identified for the decline.

3 ago 2026, 20:03 UTC

No specific news for STAAR Surgical as shares trade near unchanged. The broader market sees gains amid strong buying interest in technology stocks.

31 lug 2026, 19:52 UTC

STAAR Surgical Co shares are lower amid weakness in the Health Care Supplies sub-sector. The stock has seen modest declines since Thursday's close.

30 lug 2026, 19:29 UTC

STAAR Surgical Co. shares are lower today, reflecting a decline since Wednesday amid broader market volatility and rising Treasury yields.

29 lug 2026, 22:11 UTC

STAAR Surgical Co shares are lower in after-market hours amid significant declines in the Health Care Supplies sub-sector, with no specific news identified.

28 lug 2026, 18:56 UTC

News

STAAR Surgical Co shares declined after UBS initiated coverage with a Sell rating and set a price target of $20.00, closing at $22.95.

27 lug 2026, 19:07 UTC

STAAR Surgical Co. shares are trading lower, continuing a recent downward trend amid broader market sentiment affected by declining crude oil prices.

22 lug 2026, 18:11 UTC

News

Wedbush reiterated its OUTPERFORM rating on STAAR Surgical, maintaining a $40 price target, contributing to shares trading higher today.

21 lug 2026, 16:56 UTC

Social Media

STAAR Surgical preannounces second-quarter revenue over $90 million, up from $44.3 million last year, as shares gain amid market volatility.

20 lug 2026, 20:01 UTC

News

STAAR Surgical shares are lower amid investor concerns over sustainability despite projected Q2 sales exceeding $90 million and strong growth in China and the Americas.

Confronto tra pari

Modifica del prezzo

STAAR Surgical Co Previsione

Obiettivo di Prezzo

By TipRanks

16.92% in crescita

Previsioni per 12 mesi

Media 29.71 USD  16.92%

Alto 40 USD

Basso 20 USD

Basato su 9 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per STAAR Surgical Co - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

9 ratings

2

Acquista

6

Mantieni

1

Vendi

Sentiment

By Acuity

165 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat